Made of flexible silicone, the ring slowly releases dapivirine, an antiretroviral medicine, locally to the site of potential infection, with minimal absorption elsewhere in the body. Picture: Supplied
NEWS
In a world starved of good news under the weight of the deadly and highly infectious Covid-19 coronavirus pandemic, the field of HIV prevention and women’s sexual reproductive health has reason to celebrate.
The dapivirine vaginal ring, designed to help address women’s unmet need for new methods to protect themselves from contracting HIV, could soon be available for use by women aged 18 and older in Africa. This after getting a nod of approval from the European Medicines Agency (EMA) on Friday.
South Africans need to be in the know if we want to create a prosperous future. News24 has kept the country informed for 25 years, and we're about to enter a new chapter of fearless journalism. Join our free subscription trial to unlock this story and a world of news aimed to inform, empower, and inspire.